Identification of candidate miRNA biomarkers for facioscapulohumeral muscular dystrophy using DUX4-based mouse models

• Váldodahkkit: Andreia M. Nunes (Dahkki), Monique Ramirez (Dahkki), Takako I. Jones (Dahkki), Peter L. Jones (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: The Company of Biologists, 2021-08-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Facioscapulohumeral muscular dystrophy (FSHD) is caused by misexpression of DUX4 in skeletal myocytes. As DUX4 is the key therapeutic target in FSHD, surrogate biomarkers of DUX4 expression in skeletal muscle are critically needed for clinical trials. Although no natural animal models of FSHD exist,...